James Hays v. John Berlau

CourtCourt of Appeals for the Seventh Circuit
DecidedAugust 10, 2016
Docket15-3799
StatusPublished

This text of James Hays v. John Berlau (James Hays v. John Berlau) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
James Hays v. John Berlau, (7th Cir. 2016).

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________

No. 15-3799

IN RE: WALGREEN CO. STOCKHOLDER LITIGATION (HAYS, et al. v. WALGREEN CO., et al.) APPEAL OF: JOHN BERLAU, Objector. ____________________

Appeal from the United States District Court for the Northern District of Illinois, Eastern Division. No. 14 C 9786 — Joan B. Gottschall, Judge. ____________________

ARGUED JUNE 2, 2016 — DECIDED AUGUST 10, 2016 ____________________

Before POSNER and SYKES, Circuit Judges, and YANDLE, District Judge. * POSNER, Circuit Judge. In merger litigation the terms “strike suit” and “deal litigation” refer disapprovingly to cases in which a large public company announces an agree- ment that requires shareholder approval to acquire another

*Of the Southern District of Illinois, sitting by designation. Judge Yandle dissents from the panel’s decision. Her dissent will be issued separately in due course. 2 No. 15-3799

large company, and a suit, often a class action, is filed on be- half of shareholders of one of the companies for the sole purpose of obtaining fees for the plaintiffs’ counsel. Often the suit asks primarily or even exclusively for disclosure of details of the proposed transaction that could, in principle at least, affect shareholder approval of the transaction. But al- most all such suits are designed to end—and very quickly too—in a settlement in which class counsel receive fees and the shareholders receive additional disclosures concerning the proposed transaction. The disclosures may be largely or even entirely worthless to the shareholders, in which event even a modest award of attorneys’ fees ($370,000 in this case) is excessive and the settlement should therefore be disap- proved by the district judge. In this case, however, the dis- trict judge approved the settlement, including a narrow re- lease of claims and the fee for the plaintiff’s lawyers that the company had agreed not to oppose. A shareholder named Berlau, having objected unsuccessfully to the settlement in the district court, has appealed. In 2012 Walgreen Co. (usually referred to as “Walgreens”) acquired a 45 percent equity stake in a Swiss company named Alliance Boots GmbH, plus an option to acquire the rest of Alliance’s equity, beginning in February 2015, for a mixture of cash and Walgreens stock. In 2014 the two companies altered the deal to allow the option to be ex- ercised earlier. Walgreens announced its intent to purchase the remainder of Alliance Boots and then engineer a reor- ganization whereby Walgreens (having swallowed Alliance Boots) would become a wholly owned subsidiary of a new Delaware corporation to be called Walgreens Boots Alliance, Inc. Within two weeks after Walgreens filed a proxy state- ment seeking shareholder approval of the reorganization, No. 15-3799 3

the inevitable class action was filed, and 18 days later—less than a week before the shareholder vote—the parties agreed to settle the suit. The suit sought additional disclosures to the sharehold- ers, disclosures alleged to be likely to affect the shareholder vote. The settlement required Walgreens to issue several of the disclosures to the shareholders—that was the entire ben- efit of the settlement to the class—and released the company from liability for the other disclosure-related claims made in the suit. It also authorized class counsel to ask the district judge to award them $370,000 in attorneys’ fees, without op- position from Walgreens. The disclosures agreed to in the settlement (the parties call these the supplemental disclosures, as shall we) repre- sented only a trivial addition to the extensive disclosures al- ready made in the proxy statement: fewer than 800 new words—resulting in less than a 1 percent increase—spread over six disclosures. The supplemental disclosure deemed most significant by class counsel concerned the nomination to the board of di- rectors of Walgreens of Barry Rosenstein, who was involved in a hedge fund that had a 1.5 percent interest in Walgreens stock. The disclosure states that before his nomination he had “engaged in preliminary discussions [with Walgreens] during which [he had] expressed his views regarding Walgreens and its strategic direction and prospects,” that Walgreens had entered into a confidentiality agreement with Rosenstein’s firm, and that there had been further consulta- tions ending in Walgreens’ concluding “that Mr. Rosenstein would be a valuable addition to the Board” of Walgreens Boots Alliance. 4 No. 15-3799

The new disclosure was worthless because it was and is obvious that Walgreens would not nominate a person for election to its board of directors without discussing with the prospective nominee the company’s strategic direction and prospects. The only new thing to be gleaned from the disclo- sure related to the timing of the conversations. Rosenstein had been nominated on September 5, 2014, and the disclo- sure indicated that there had been conversations stretching back at least a month. But even without that revelation, the shareholders would have assumed that Rosenstein’s ap- pointment to the board had not happened overnight, and the disclosure revealed no further details about the period or content of the pre-nomination consultations. A second supplemental disclosure concerned the alloca- tion of stock in Walgreens Boots Alliance to two investment groups, SP Investors and KKR Investors, after the merger. The disclosure estimated that SP Investors would have about 11.3 percent of the shares and KKR Investors about 4.6 per- cent. But as these estimates could be derived by simple arithmetic from data in the proxy statement, the disclosure added nothing. See, e.g., Werner v. Werner, 267 F.3d 288, 299– 300 (3d Cir. 2001). Supplemental disclosure number three: in 2014, shortly before Walgreens and Alliance decided to merge, Walgreens’ executive vice president and chief financial of- ficer and president of its international division, Wade D. Mi- quelon, had resigned from the company and sued it for def- amation. The proxy statement did not mention Miquelon’s resignation or his suit; the supplemental disclosure listed the claims made in his suit and said that Walgreens had denied them. There was no suggestion that the suit (seven of the No. 15-3799 5

nine counts of which were dismissed in 2015) could have had a significant impact on the formation or operation of Walgreens Boots Alliance, or that it was even related to the formation of the new company. Supplemental disclosure number four: The proxy state- ment included a bullet-point list of risk factors that the Walgreens board had considered in deciding whether to merge with Alliance Boots. The supplemental disclosure added four to the list—but all were based on language found in the proxy statement. The additional disclosure provided no new information to shareholders. Supplemental disclosure five: The proxy statement noted that Stefano Pessina, who was designated to become CEO of Walgreens Boots Alliance and had interests in Alliance Boots resulting from his affiliation with SP Investors had, along with one other member of Walgreens’ board, not voted on whether to approve the merger. The supplemental disclo- sure explained that “as a result of their interest in the pro- posed transaction” the two had recused themselves from the Board’s decision to exercise Walgreens’ option to buy the rest of Alliance Boots. The supplemental disclosure merely stated the reason they’d not voted, and there is nothing to suggest that the disclosure of that reason could have upend- ed the merger. And their recusal from voting on the reorgan- ization because of their financial interest in it had been high- lighted elsewhere in the proxy statement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

TSC Industries, Inc. v. Northway, Inc.
426 U.S. 438 (Supreme Court, 1976)
In Re Aqua Dots Products Liability Litigation
654 F.3d 748 (Seventh Circuit, 2011)
Appert v. Morgan Stanley Dean Witter, Inc.
673 F.3d 609 (Seventh Circuit, 2012)
Elizabeth Werner v. Eric Werner
267 F.3d 288 (Third Circuit, 2001)
In Re Revlon, Inc. Shareholders Litigation
990 A.2d 940 (Court of Chancery of Delaware, 2010)
Kent Eubank v. Pella Corporation
753 F.3d 718 (Seventh Circuit, 2014)
Crawford v. Equifax Payment Services, Inc.
201 F.3d 877 (Seventh Circuit, 2000)
In re Trulia, Inc. Stockholder Litigation
129 A.3d 884 (Court of Chancery of Delaware, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
James Hays v. John Berlau, Counsel Stack Legal Research, https://law.counselstack.com/opinion/james-hays-v-john-berlau-ca7-2016.